Tamoxifen for Advanced Solid Pseudopapillary Tumor of the Pancreas

Tamoxifen for Solid Pseudopapillary Tumor of the Pancreas

Trial Details

NCT ID
NCT06914674
Phase
PHASE2
Sponsor
Fudan University
Status
RECRUITING
Cancer Type
Pancreatic Cancer
Interventions
  • Tamoxifen 20 mg
Locations (sample)
  • Shanghai, China|31.22222,121.45806

Key Eligibility Criteria

  • Age 14-80 years.
  • Histologically confirmed advanced SPTP with ER/PR+.
  • Advanced disease:
  • Unresectable primary tumor or distant metastasis (liver, lung, peritoneum, etc.).

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Pancreatic Cancer Trials on Trialify →